Adicet Bio, Inc. Share Price Today: Live Updates & Key Insights

Adicet Bio, Inc. share price today is $6.92, up -2.12%. The stock opened at $6.97 against the previous close of $7.07, with an intraday high of $7.09 and low of $6.84.

Adicet Bio, Inc. Share Price Chart

Adicet Bio, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Adicet Bio, Inc. Share Price Performance

$6.92 -0.0212(-2.12%) ACET at 23 Mar 2026 11:52 AM Biotechnology
Lowest Today 6.84
Highest Today 7.09
Today’s Open 6.97
Prev. Close 7.07
52 Week High 17.44
52 Week Low 6.41
Day’s Range: Low 6.84 High 7.09
52-Week Range: Low 6.41 High 17.44
1 day return -
1 Week return -3.62
1 month return -0.14
3 month return +1308.76
6 month return +739.1
1 year return +657.42
3 year return +15.45
5 year return -53.02
10 year return -

Adicet Bio, Inc. Institutional Holdings

Orbimed Advisors, LLC 10.71

RA Capital Management, LLC 9.88

Woodline Partners LP 6.51

TANG CAPITAL MANAGEMENT LLC 5.35

Franklin Biotechnology Discv A(acc)USD 4.18

Vanguard Group Inc 3.03

Adage Capital Partners Gp LLC 2.86

Prosight Management, LP 2.61

Renaissance Technologies Corp 2.53

The Goldman Sachs Group Inc 2.44

Franklin Biotechnology Discovery A 2.35

Stonepine Capital Management Llc 2.29

Alyeska Investment Group, L.P. 2.12

Vanguard Total Stock Mkt Idx Inv 1.97

The Carlyle Group Inc 1.92

NEXTBio Capital Management LP 1.64

Two Sigma Investments LLC 1.51

Acadian Asset Management LLC 1.47

Vanguard Institutional Extnd Mkt Idx Tr 1.03

Regeneron Pharmaceuticals Inc 0.63

Bridgeway Ultra-Small Company 0.53

Fidelity Extended Market Index 0.46

BlackRock Inc 0.38

Johnson & Johnson 0.24

Barclays PLC 0.20

Spartan Extended Market Index Pool F 0.19

Fidelity Total Market Index 0.18

State Street Corp 0.16

Blackrock Extended Mkt Fund CF 0.11

NT Ext Equity Mkt Idx Fd - L 0.11

Fidelity Series Total Market Index 0.11

Extended Equity Market Fund K 0.10

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Spartan Total Market Index Pool G 0.07

Vanguard Balanced Index Inv 0.06

Bridgeway Ultra-Small Company Market 0.06

Vanguard U.S. Eq Idx £ Acc 0.05

Northern Trust Extended Eq Market Idx 0.05

Fidelity Nasdaq Composite Index 0.05

Blackstone Alternative Multi-Strategy I 0.01

Adicet Bio, Inc. Market Status

Strong Buy: 6

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Adicet Bio, Inc. Fundamentals

Market Cap 66.43 M

PB Ratio 0.4261

PE Ratio 0.0

Enterprise Value -75.95 M

Total Assets 192.36 M

Volume 96226

Adicet Bio, Inc. Company Financials

Annual Revenue FY23:0 0.0M, FY23:24990000 25.0M, FY22:9730000 9.7M, FY21:17903000 17.9M, FY20:995000 1.0M

Annual Profit FY23:-6098000 -6.1M, FY23:24990000 25.0M, FY22:9730000 9.7M, FY21:17903000 17.9M, FY20:995000 1.0M

Annual Net worth FY23:-142658000 -142.7M, FY23:-67029000 -67.0M, FY22:-61999000 -62.0M, FY21:-36678000 -36.7M, FY20:-28138000 -28.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-1600000 -1.6M, Q2/2025:-1600000 -1.6M, Q1/2025:-1680000 -1.7M, Q3/2024:null 0.0M, Q2/2024:-1602000 -1.6M

Quarterly Net worth Q3/2025:-26856000 -26.9M, Q2/2025:-31217000 -31.2M, Q1/2025:-28214000 -28.2M, Q3/2024:-30478000 -30.5M, Q2/2024:-29901000 -29.9M

About Adicet Bio, Inc. & investment objective

Company Information Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Organisation Biotechnology

Employees 152

Industry Biotechnology

CEO Mr. Chen Schor BA, CPA, M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Adicet Bio, Inc. FAQs

What is the share price of Adicet Bio, Inc. today?

The current share price of Adicet Bio, Inc. is $6.92.

Can I buy Adicet Bio, Inc. shares in India?

Yes, Indian investors can buy Adicet Bio, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Adicet Bio, Inc. shares in India?

You can easily invest in Adicet Bio, Inc. shares from India by:

Can I buy fractional shares of Adicet Bio, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Adicet Bio, Inc.?

Adicet Bio, Inc. has a market cap of $66.43 M.

In which sector does Adicet Bio, Inc. belong?

Adicet Bio, Inc. operates in the Biotechnology sector.

What documents are required to invest in Adicet Bio, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Adicet Bio, Inc.?

The PE ratio of Adicet Bio, Inc. is N/A and the PB ratio is 0.43.